THE STIMULATORY ACTION OF THE CALCIUM-CHANNEL AGONIST BAY K-8644 ON ISOLATED DUODENAL MUSCLE - ANTAGONISM BY NIFEDIPINE AND VERAPAMIL

被引:12
作者
CORUZZI, G [1 ]
POLI, E [1 ]
机构
[1] UNIV PARMA, INST PHARMACOL, I-43100 PARMA, ITALY
关键词
D O I
10.1007/BF00634251
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The action of the novel dihydropyridine analogue Bay K 8644 has been evaluated on the rat isolated duodenal muscle. Bay K 8644 (0.3 nmol/l to 1 pmol/l) increased both the tone and the phasic movements of the duodenum; the maximum response was about 60% of that to acetylcholine. Nifedipine (30 nmol/l) induced a parallel shift of the concentration-response curve to this compound to the right, without depressing the maximum response; conversely, verapamil (30 nmol/l) caused an unsurmountable antagonism. Incubation of the strips in Ca2+-free medium reduced the contractile response to the calcium agonist. The spasmogenic effect of Bay K 8644 was inhibited by atropine (0.1 pmol/l) which caused a significant reduction in the maximum repsonse to the compound. The competitive interaction between Bay K 8644 and nifedipine is consistent with an action at the same dihydropyridine binding site in the calcium channel and suggests that these compounds could be selective probes for detecting the dihydropyridine receptor also in the intestinal smooth muscle. The sensitivity of the contractile effect of Bay K 8644 to atropine may indicate an action of this compound in the cholinergic system, probably mediated by a release of acetylcholine from the nerve terminal rather than due to a direct stimulatory action at muscarinic receptor in the smooth muscle.
引用
收藏
页码:290 / 292
页数:3
相关论文
共 13 条
[1]   INTERACTION OF THE CALCIUM-CHANNEL ACTIVATING H-3 BAY K-8644 AND INHIBITING H-3 VERAPAMIL WITH SPECIFIC RECEPTOR-SITES ON CULTURED BEATING MYOCARDIAL-CELLS [J].
BELLEMANN, P .
JOURNAL OF RECEPTOR RESEARCH, 1984, 4 (1-6) :571-585
[2]  
BERTACCINI G, 1979, SCAND J GASTROENTERO, V14, P87
[3]  
BOLGER GT, 1983, J PHARMACOL EXP THER, V225, P291
[4]  
CORUZZI G, 1984, 19TH CZECH C GASTR
[5]   CALCIUM CHANNELS - DIRECT IDENTIFICATION WITH RADIOLIGAND BINDING-STUDIES [J].
GLOSSMANN, H ;
FERRY, DR ;
LUBBECKE, F ;
MEWES, R ;
HOFMANN, F .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1982, 3 (11) :431-437
[6]   SITES OF ACTION OF CA-2+ CHANNEL INHIBITORS [J].
JANIS, RA ;
SCRIABINE, A .
BIOCHEMICAL PHARMACOLOGY, 1983, 32 (23) :3499-3507
[7]   SPECIFIC BINDING OF A CALCIUM-CHANNEL ACTIVATOR, [H-3]-LABELED BAY-K-8644, TO MEMBRANES FROM CARDIAC-MUSCLE AND BRAIN [J].
JANIS, RA ;
RAMPE, D ;
SARMIENTO, JG ;
TRIGGLE, DJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 121 (01) :317-323
[8]  
MIKKELSEN E, 1985, ACTA PHARMACOL TOX, V56, P44
[9]   CALCIUM-ANTAGONIST RECEPTOR-BINDING SITES LABELED WITH [NITRENDIPINE-H-3 [J].
MURPHY, KMM ;
SNYDER, SH .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1982, 77 (2-3) :201-202
[10]   NOVEL DIHYDROPYRIDINES WITH POSITIVE INOTROPIC ACTION THROUGH ACTIVATION OF CA-2+ CHANNELS [J].
SCHRAMM, M ;
THOMAS, G ;
TOWART, R ;
FRANCKOWIAK, G .
NATURE, 1983, 303 (5917) :535-537